Wilmas Kelly, Wohlmuth-Wieser Iris, Duvic Madeleine
John P. and Kathrine G. McGovern Medical School at the University of Texas Health Science Center, Houston, Texas Department of Dermatology, The University of Texas, MD Anderson Cancer Center, Houston, Texas.
Dermatol Online J. 2017 Aug 15;23(8):13030/qt6zx243zm.
The term telangiectasia macularis eruptiva perstans (TMEP) was originally used to describe a rare form of cutaneous mastocytosis (CM) that was limited to the skin with lesions consisting of irregular, telangiectatic macules ranging in color from red to brown. Recent guidelines, however, recommended that the sole presence of telangiectasias should not form the basis of a distinct variant of CM. We conducted a review of the literature from 1930 to 2017 and found 76 cases that were reported as TMEP. Owing to a general misconception about diagnosis of CM and SM, there is a need for further discussion and awareness of the newly proposed World Health Organization (WHO) guidelines.
持久性发疹性斑状毛细血管扩张症（TMEP）这一术语最初用于描述一种罕见的皮肤肥大细胞增多症（CM），其仅限于皮肤，皮损由不规则的、毛细血管扩张性斑疹组成，颜色从红色到棕色不等。然而，最近的指南建议，仅存在毛细血管扩张不应构成CM的一个独特变体的依据。我们对1930年至2017年的文献进行了回顾，发现有76例被报告为TMEP。由于对CM和SM诊断的普遍误解，有必要对世界卫生组织（WHO）新提出的指南进行进一步讨论并提高认识。
